Literature DB >> 30790676

Structural connectivity in schizophrenia and bipolar disorder: Effects of chronicity and antipsychotic treatment.

Benjamín Cea-Cañas1, Rodrigo de Luis2, Alba Lubeiro3, Javier Gomez-Pilar4, Eva Sotelo5, Pilar Del Valle5, Marta Gómez-García5, Adrián Alonso-Sánchez5, Vicente Molina6.   

Abstract

Previous studies based on graph theory parameters applied to diffusion tensor imaging support an alteration of the global properties of structural connectivity network in schizophrenia. However, the specificity of this alteration and its possible relation with chronicity and treatment have received small attention. We have assessed small-world (SW) and connectivity strength indexes of the structural network built using fractional anisotropy values of the white matter tracts connecting 84 cortical and subcortical regions in 25 chronic and 18 first episode (FE) schizophrenia and 24 bipolar patients and 28 healthy controls. Chronic schizophrenia and bipolar patients showed significantly smaller SW and connectivity strength indexes in comparison with controls and FE patients. SW reduction was driven by increased averaged path-length (PL) values. Illness duration but not treatment doses were negatively associated with connectivity strength, SW and PL in patients. Bipolar patients exposed to antipsychotics did not differ in SW or connectivity strength from bipolar patients without such an exposure. Executive functions and social cognition were related to SW index in the schizophrenia group. Our results support a role for chronicity but not treatment in structural network alterations in major psychoses, which may not differ between schizophrenia and bipolar disorder, and may hamper cognition.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antipsychotic agents; Bipolar disorder; Fractional anisotropy; Schizophrenia; Small-world; Structural connectivity

Mesh:

Substances:

Year:  2019        PMID: 30790676     DOI: 10.1016/j.pnpbp.2019.02.006

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

1.  Negative symptoms are associated with modularity and thalamic connectivity in schizophrenia.

Authors:  Adem Bayrakçı; Nabi Zorlu; Merve Karakılıç; Funda Gülyüksel; Berna Yalınçetin; Elif Oral; Fazıl Gelal; Emre Bora
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-03       Impact factor: 5.270

2.  Aberrant Subnetwork and Hub Dysconnectivity in Adult Bipolar Disorder: A Multicenter Graph Theory Analysis.

Authors:  Leila Nabulsi; Genevieve McPhilemy; Stefani O'Donoghue; Dara M Cannon; Liam Kilmartin; Denis O'Hora; Samuel Sarrazin; Cyril Poupon; Marc-Antoine D'Albis; Amelia Versace; Marine Delavest; Julia Linke; Michèle Wessa; Mary L Phillips; Josselin Houenou; Colm McDonald
Journal:  Cereb Cortex       Date:  2022-05-14       Impact factor: 4.861

3.  Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.

Authors:  Johanna Seitz-Holland; Suheyla Cetin-Karayumak; Matcheri Keshavan; Marek Kubicki; Joanne D Wojcik; Amanda Lyall; James Levitt; Martha E Shenton; Ofer Pasternak; Carl-Fredrik Westin; Madhura Baxi; Sinead Kelly; Raquelle Mesholam-Gately; Mark Vangel; Godfrey Pearlson; Carol A Tamminga; John A Sweeney; Brett A Clementz; David Schretlen; Petra Verena Viher; Katharina Stegmayer; Sebastian Walther; Jungsun Lee; Tim Crow; Anthony James; Aristotle Voineskos; Robert W Buchanan; Philip R Szeszko; Anil K Malhotra; Yogesh Rathi
Journal:  Mol Psychiatry       Date:  2021-01-22       Impact factor: 13.437

4.  Different patterns of white matter microstructural alterations between psychotic and non-psychotic bipolar disorder.

Authors:  Dong-Kyun Lee; Hyeongrae Lee; Vin Ryu; Sung-Wan Kim; Seunghyong Ryu
Journal:  PLoS One       Date:  2022-03-18       Impact factor: 3.240

5.  Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated.

Authors:  Chunyan Luo; Rebekka Lencer; Na Hu; Yuan Xiao; Wenjing Zhang; Siyi Li; Su Lui; Qiyong Gong
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-29       Impact factor: 5.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.